Sign Out
Patients must be advised to inform the doctor or pharmacist if they are taking or have recently taken any other medicines including medicines obtained without a prescription.
No interaction studies on living subjects (in vivo) have been performed. Based on laboratory (in vitro) data, no inhibition of Cytochrome P450 enzymes is expected in living subjects.
If the patient is taking monoamine-oxidase inhibitors [MAOIs, including MAO subtype B (e.g., selegiline)], which are used to treat depression or Parkinson's disease, they must be advised to inform the physician, as these medicines may increase the exposure of Betaserc.
As betahistine is similar in structure to histamine, interaction of betahistine with antihistamines may affect the efficacy of one of these drugs. Patients must be advised to inform the doctor if they are taking an antihistamine before taking Betaserc.
Continue with Google